Table 3.
Group | Blood glucose level (mg/dl) |
||||
---|---|---|---|---|---|
0hr | 2hr | 4hr | 6hr | 8hr | |
DW 10 mg/kg | 320.33 ± 6.94 | 318.00 ± 9.54 | 326.67 ± 5.67 | 327.33 ± 8.65 | 322.67 ± 5.94 |
GLC 5 mg/kg | 343.83 ± 11.25 | 268.50 ± 16.54β3 | 205.00 ± 6.89β3,n3 | 180.33 ± 16.54β3,n3 | 166.00 ± 11.25β3,n3 |
AQF 100 mg/kg | 309.67 ± 9.65 | 292.33 ± 10.36 | 282.17 ± 11.02 | 268.83 ± 11.25 | 262.67 ± 13.52 |
AQF 200 mg/kg | 325.00 ± 15.32 | 280.33 ± 9.67 | 267.50 ± 5.67β1 | 254.83 ± 19.54β2,n1 | 238.17 ± 9.65β3,n3 |
AQF 400 mg/kg | 298.17 ± 9.67 | 250.17 ± 12.54β3\1 | 245.50 ± 13.54β2,n1 | 231.17 ± 15.68β3,n3 | 183.00 ± 14.52β3,n3 |
EAF 100 mg/kg | 327.67 ± 14.25 | 299.17 ± 8.67 | 281.83 ± 9.82 | 255.67 ± 13.24n1 | 247.17 ± 8.69β1,n2 |
EAF 200 mg/kg | 325.50 ± 11.07 | 267.67 ± 15.64β2 | 255.33 ± 7.68β2,n1 | 247.83 ± 17.36β3,n2 | 242.50 ± 10.36β3,n2 |
EAF 400 mg/kg | 314.83 ± 8.87 | 257.67 ± 13.54β1 | 245.33 ± 14.25β2,n1 | 236.50 ± 9.58β2,n3 | 224.00 ± 9.58β3,n3 |
CHF 100 mg/kg | 307.83 ± 10.24 | 287.17 ± 16.54 | 273.50 ± 14.56 | 268.00 ± 15.21 | 262.00 ± 14.27n1 |
CHF 200 mg/kg | 318.00 ± 9.54 | 286.83 ± 12.34 | 274.67 ± 9.87 | 269.67 ± 9.58 | 255.17 ± 11.38β1,n1 |
CHF 400 mg/kg | 328.50 ± 7.58 | 286.33 ± 11.58 | 269.67 ± 13.24β1 | 260.67 ± 10.57β2,n1 | 254.17 ± 9.68β3,n1 |
Each value represents mean ± SEM; n=6 for each treatment. nCompared to the negative control, βcompared to baseline blood glucose level. 1p < 0.05, 2p <0.01, and 3p < 0.001, AQF100=aqueous fraction 100 mg/kg, AQF200=aqueous fraction 200 mg/kg, AQF400=aqueous fraction 400 mg/kg, EAF100=ethyl acetate fraction 100 mg/kg, EAF200=ethyl acetate fraction 200 mg/kg, EAF400=ethyl acetate fraction 400mg/kg, CFF100=chloroform fraction 100 mg/kg, CFF200=chloroform fraction 200 mg/kg, CFF400=chloroform fraction 400 mg/kg, DW10=Distilled water 10 ml/kg and GLC5=glibenclamide 5 mg/kg.